| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | FPW3780T3E |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Sclerostin inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteogenesis Imperfecta | 3 | D010013 | ClinicalTrials |
| Kidney Diseases | 2 | D007674 | ClinicalTrials |
| Hypophosphatasia | 2 | D007014 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297918 |
| FDA SRS | FPW3780T3E |
CONTENTS